ArticleFrontiers in cardiovascular medicine2025
The relationship between blood glucose and clinical outcomes after extracorporeal circulation: a retrospective cohort study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A miniaturized mouse extracorporeal circulation model to characterize early hematologic and metabolic alterations.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative blood glucose levels significantly impact outcomes in cardiac surgery patients undergoing extracorporeal circulation (ECC) auxiliary to open heart surgery. While hypoglycemia and hyperglycemia are known risk factors for adverse outcomes, the optimal glycemic range for patients undergoing ECC remains unclear. This research examined the relationship between blood glucose levels and 90-day mortality in this high-risk group. Methods: The data for this research were obtained from the Medical Information Mart for Intensive Care-IV database version 2.2(MIMIC-IV 2.2), including 4,033 patients who underwent ECC-assisted open-heart surgery. Patients were classified into quartiles based on blood glucose values measured within a 24 h period following admission to the ICU. The study's primary outcome was the 90-day mortality, and the duration of hospital and ICU stays were considered secondary outcomes. Kaplan-Meier survival analysis, Multivariate Cox regression models, smooth curve fitting, Restricted Cubic Spline (RCS) curve, and subgroup analyses were conducted to evaluate the relationship between blood glucose levels and patient outcomes. Results: Higher blood glucose levels were significantly related to increased 90-day mortality. The analysis revealed the nonlinear relation between blood glucose and 90 days mortality, with an inflection point at 119 mg/dl ( Conclusion: Elevated postoperative blood glucose values were related to an increased 90-day mortality in patients who underwent ECC. When blood glucose levels exceeded 119 mg/dl, blood glucose levels were positively associated with 90-day postoperative mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.